Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 21 → 22·19:33, 17 Oct 2025
Difference between revision 21 and revision 22 of Shanghai Wibson Biotechnology. 9 lines changed; the page grew by 1,089 bytes.
| Revision 21 — 14:46, 30 Sep 2025 HalfLifeHavel (talk) attribute the documentation description to the purchaser reports it comes from 12,527 bytes +1,119 | Revision 22 — 19:33, 17 Oct 2025 Chromatokid (talk) fix hyphenation per PP:MOS 13,616 bytes +1,089 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://shanghaiwibsonbiotechnology.net/ Go to the SWB catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} | 78 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 82 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | 84 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. |
| 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| + | 86 | ||
| + | 87 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 88 | ||
| + | 89 | == Regulatory position and legal status == | |
| + | 90 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 91 | ||
| + | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| 84 | 93 | ||
| 85 | == Notability and coverage == | 94 | == Notability and coverage == |